Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
Takaki HiwasaHao WangKen-Ichiro GotoSeiichiro MineToshio MachidaEiichi KobayashiYoichi YoshidaAkihiko AdachiTomoo MatsutaniMizuki SataKazumasa YamagishiHiroyasu IsoNorie SawadaShoichiro TsuganeMitoshi KunimatsuIkuo KamitsukasaMasahiro MoriKazuo SugimotoAkiyuki UzawaMayumi MutoSatoshi KuwabaraYoshio KobayashiMikiko OhnoEiichiro NishiAkiko HattoriMasashi YamamotoYoshiro MaezawaKazuki KobayashiRyoichi IshibashiMinoru TakemotoKoutaro YokoteHirotaka TakizawaTakashi KishimotoKazuyuki MatsushitaSohei KobayashiFumio NomuraTakahiro ArasawaAkiko KagayaTetsuro MaruyamaHisahiro MatsubaraMinako TomiitaShinsaku HamanakaYushi ImaiTomoo NakagawaNaoya KatoJiro TeradaTakuma MatsumuraYusuke KatsumataAkira NaitoNobuhiro TanabeSeiichiro SakaoKoichiro TatsumiMasaaki ItoFumiaki ShiratoriMakoto SumazakiSatoshi YajimaHideaki ShimadaMikako ShirouzuShigeyuki YokoyamaTakashi KudoHirofumi DoiKatsuro IwaseHiromi AshinoShu-Yang LiMasaaki KubotaGo TomiyoshiNatsuko ShinmenRika NakamuraHideyuki KurodaYasuo IwadatePublished in: BMC medicine (2021)
Serum antibody levels of DIDO1, FOXJ2, and CPSF2 are useful in predicting the onset of atherosclerosis-related AIS caused by kidney failure, hypertension, and DM, respectively.